Background {#Sec1}
==========

Children with congenital heart disease (CHD) are at elevated risk for behavioral, emotional, and cognitive problems in childhood \[[@CR1], [@CR2]\], adolescence, and adulthood \[[@CR3]\]. Previous cohort studies from our research group have indicated that CHD-children are two times more likely to develop psychopathology than healthy children (16--27% versus 10% in the general population) - irrespective of the type of cardiac defect \[[@CR4], [@CR5]\]. Especially internalizing behavior problems, problems with social contacts, and reduced quality of life have been reported \[[@CR6]\]. Moreover, neuropsychological problems and intellectual impairments are well known in these children \[[@CR7], [@CR8]\] and elevated percentages of CHD-children attending special education (24% versus 4% in norm) have been reported \[[@CR3]\]. The most common morbidity affecting the quality of life in school-aged children with CHD is the combination of behavioral/emotional problems, developmental delay, and school difficulties \[[@CR9]\]. Such problems can have long-term consequences: two long-term studies have shown that adults with CHD overall had a lower occupational and educational status compared with the general population \[[@CR10], [@CR11]\]. Furthermore, children with CHD often have reduced exercise capacity and participate less in exercise and sports, which has been associated with a lower quality of life \[[@CR12]\]. It has been shown that participation in an exercise program improves quality of life of children with CHD \[[@CR13]\].

In addition, parental factors play a crucial role in children's psychosocial wellbeing \[[@CR2], [@CR14]--[@CR16]\]. Maternal mental health and worry have appeared to be more important predictors of psychosocial wellbeing of children with CHD than illness severity \[[@CR2], [@CR17], [@CR18]\]. Unfortunately, parents of children with CHD are also at risk for psychosocial problems themselves (e.g. anxiety, depression; 1 year prevalence 7--22%) \[[@CR19]\].

Considering the above and the fact that milestones such as starting kindergarten and primary school present more challenges for children with CHD and their parents than for families with healthy children \[[@CR20]\], a family-based psychosocial intervention tailored to their needs when starting school is required \[[@CR19], [@CR21], [@CR22]\]. This need has also been expressed by parents and patients \[[@CR21], [@CR23]\]. Through such an intervention, psychosocial problems of children with CHD and their parents may be recognized, reduced or prevented. In addition, school functioning, emotional resilience, and sports participation of these children can be improved \[[@CR21], [@CR24]\]. Until now, the only evidence-based intervention in this field is the Congenital Heart Disease Intervention Program (CHIP) -- School \[[@CR2]\]. The CHIP-School study aimed to promote psychosocial wellbeing of preschoolers with CHD indirectly by providing an intervention for their parents. CHIP-School resulted in significant gains in maternal mental health, reduced perceived strain on the family, and less school absence of the child. As to child psychosocial wellbeing, only a non-significant, though positive, trend was found \[[@CR2]\].

A limitation of CHIP-School was that a separate child module was not included. Therefore, in collaboration with the original authors of the previous CHIP intervention, we have translated, extended and modified CHIP, by adding a tailored child module for CHD-children and their siblings. The child module includes evidence-based cognitive behavioral exercises \[[@CR25]\] and sports exercises. The newly developed CHIP-Family is a psychosocial intervention for 4- to 7-year-old children who have undergone at least one medical intervention for CHD and are starting or attending kindergarten or primary school (first or second year) and their families.

The aim of this study is (1) to test the effects of CHIP-Family on parental mental health and psychosocial wellbeing of CHD-children who are starting or attending kindergarten or primary school and to (2) identify baseline psychosocial and medical predictors for the effectiveness of CHIP-Family.

Methods {#Sec2}
=======

This study is a single-center, single-blinded randomized controlled trial (RCT) comparing the effects of the CHIP-Family intervention with care as usual (CAU; regular medical treatment) on mental health of parents and psychosocial wellbeing of young children with CHD. This RCT is designed according to the CONSORT guidelines \[[@CR26]\].

Inclusion and exclusion criteria {#Sec3}
--------------------------------

Over a one-year period (September 2016 -- September 2017) children and their families living in the Netherlands will be recruited. Eligible are all children who (1) underwent at least one invasive procedure (catheter intervention or surgery) for CHD and (2) are starting or attending kindergarten or primary school (first or second year) at the time of first assessment (as the children are approximately 4--7 years old). Exclusion criteria are: (1) child's intellectual impairment (IQ \< 70) as ascertained by previous standardized assessment or diagnosed by a clinician, (2) insufficient mastery of the Dutch language, and (3) prematurely born children (gestational age at birth \< 37 weeks) with no other CHD than a patent ductus arteriosus.

Recruitment and procedure {#Sec4}
-------------------------

Parents of 4- to 7-year-old children who receive treatment at the department of pediatric cardiology of the Erasmus Medical Center -- Sophia Children's Hospital and eligible members of the Dutch Patient Association for Congenital Heart Disease whose children receive treatment in a cardiac centre in the Netherlands will receive an information leaflet explaining the purpose and procedures of the study. Before inclusion, parents will receive a verbal explanation of the trial. After obtaining written parental informed consent, patients are randomly allocated to the CHIP-Family intervention or CAU group. To avoid a delay of more than 1 month between baseline assessment and the intervention, patients are randomized prior to the baseline assessment. Patients are allocated to the CHIP-Family intervention or CAU group by means of block randomization, performed by an independent researcher. Randomization will be stratified by CHD severity (limited to no residual heart defects or moderate to severe residual heart defects \[after medical intervention\]; see Table [1](#Tab1){ref-type="table"}) and school year (kindergarten or primary school). To avoid bias, the researcher performing the assessments and analyses will be blinded. Considering the nature of the CHIP-Family intervention, it is not possible to blind the participants and the health care professionals providing the intervention.Table 1Stratification factor "CHD severity"Type 1Type 2Limited to no residual heart defects after medical interventionModerate to severe residual heart defects after medical interventionAtrial Septal Defect (ASD)ALCAPA (Anomalous Left Coronary Artery from the Pulmonary Artery)Patent Ductus ArteriosusAortic Valve StenosisPulmonary valve stenosisAtrioventricular Septal Defect (AVSD)Total Anomalous Pulmonary Venous ConnectionCoarctation of the AortaVentricular Septal Defect (VSD)Complex Biventricular (e.g. Truncus Arteriosus, aortic arch defects)Double Inlet Ventricle -- Fontan circulationEbstein's AnomalySubvalvular Aortic StenosisTetralogy of Fallot (TOF)TOF with MAPCA (Main Aorta to Pulmonary Connecting Artery)Transposition of the Great Arteries

Intervention {#Sec5}
------------

CHIP-Family consists of a parent module and a child module. Parents and children participate in a separate, but simultaneously given, 6-h group workshop. An overview of the content of the workshops is given in Table [2](#Tab2){ref-type="table"}. Over the course of a 11-month period (Nov. 2016 -- Sept. 2017) 11 workshops will be given to 3 to 5 families per workshop.Table 2Outline of the CHIP-Family workshopsHealth care professional(s)ContentParent workshop Psychologists • Problem prevention therapy \[[@CR48]\]. A DO ACT acronym is applied: **D**efine problem and turn into a specific goal; **O**ption brainstorm; **A**ssess pros and cons of various options; **C**hoose a strategy; **T**ake action and evaluate • Psychoeducation • General parenting skills • Specific parenting skills for children with CHD Pediatric cardiologist • Information on medical diagnoses, treatments, future issues (e.g., career, pregnancy), insurance, and healthy living (e.g., sports, diet)Child workshop Psychologists • Relaxation • Promoting autonomy • Strengthening self-esteem • Making friends • Problem solving skills • Positive thinking Physiotherapists • Playful, age-attuned sports exercises: warming-up, fitness, gross motor skills, balance, aiming, and catching

Parent module {#Sec6}
-------------

The parent module is based on the evidence-based CHIP-School protocol \[[@CR2]\].

### Workshop {#Sec7}

The parent workshop focuses on problem prevention therapy, psychoeducation, general parenting skills, skills specific to parenting a child with CHD (given by two senior psychologists with expertise in the field; 4 h), and medical issues (given by a pediatric cardiologist; 1 h). The lunch break (1 h) offers families more opportunity to interact and share (similar) experiences. During the workshop, parents receive a manual which contains an overview of the topics that will be covered during the workshop and a home assignment on problem prevention therapy. Parents also receive handouts and a teacher information leaflet.

### Follow-up booster session {#Sec8}

Approximately 4 weeks after the workshop, parents receive an individual follow-up booster session with a psychologist who was present during the parent workshop and a psychologist who was present during the child workshop. Questions or worries that may have come up after the workshop regarding their child with CHD or their family members are discussed. Also, aspects of the workshop which have been (most) helpful for parents and will be helpful in the future are reviewed. Moreover, the session focuses on the problem prevention home assignment and on how to promote future use of problem prevention therapy.

Child module {#Sec9}
------------

To normalize participation in the workshop and to stimulate practice at home, each child is allowed to bring a 4- to 10-year-old sibling or friend. The psychological exercises (given by two junior psychologists; 4 h) are based on the evidence-based cognitive behavioral therapy Fun FRIENDS protocol \[[@CR25]\]. The exercises are provided in a playful manner and focus on regulating emotions, relaxation, promoting autonomy, strengthening self-esteem, making friends, problem solving skills, and positive thinking. The playful, age-attuned sports exercises (given by a physiotherapist and assistant physiotherapist; 1 h) are based on a standardized training program. Previous research has shown that these exercises are effective in improving the quality of life in children with CHD \[[@CR13]\].

Training and protocol adherence {#Sec10}
-------------------------------

CHIP-Family is performed in a standardized manner. Prior to the workshops, four senior and five junior psychologists receive a one-day CHIP-training by developmental psychologists Prof. Dr. McCusker and Dr. Doherty, developers of the original CHIP-protocol. To ensure consistency, the same senior and junior psychologist will be present at each workshop. In both the parent and child workshops, another psychologist will be present. Master's students in Psychology will assess treatment integrity during the parent and child workshop through a standardized form. Follow-up sessions are audiotaped and treatment integrity is assessed through a standardized form afterwards.

Outcome measures {#Sec11}
----------------

An overview of all variables and questionnaires per assessment moment is given in Table [3](#Tab3){ref-type="table"}. All questionnaires are (inter)nationally validated and Dutch normative data is available. Children and their families are enrolled into the study in groups of 6 to 10 families (3 to 5 families in the CHIP-group and 3 to 5 families in the CAU group). In both the CHIP-Family and the CAU condition, the first assessment will take place within 2 weeks before the CHIP-Family intervention (T1) and the follow-up post-assessment (T2) will take place 6 months after T1. Patients who are randomized into the CHIP-Family intervention group complete a social validity questionnaire assessing satisfaction with regards to the CHIP-program within 2 weeks after the intervention and at T2. All questionnaires are completed at home through a secure website.Table 3Assessment instruments and moments of assessmentInstrumentVariableAssessment momentT1Direct follow-upT2Primary outcomes Child Behavior Checklist (CBCL) \[[@CR32]\]Child behavioral/emotional problemsM, FM, F Symptom Checklist-90-Revised (SCL-90-R) \[[@CR29]\]Parental mental healthM, FM, FSecondary outcomes Rotterdam Quality of Life interview \[[@CR30]\]School days sick/absentM, FM, F, T Rotterdam Knowledge Questionnaire \[[@CR31]\]Disease-specific knowledge and illness perceptionM, FM, F Teacher Report Form (TRF) \[[@CR32]\]School functioning -T Behavior Rating Inventory of Executive Functioning (BRIEF) \[[@CR34], [@CR35]\] or BRIEF-Preschool Version (BRIEF-P) \[[@CR36]\]Executive functioningM, FM, F, T Adjusted Groningen Enjoyment Questionnaire \[[@CR37]\]Sports participation, enjoyment of physical activityM, FM, F, T 2 sports-related questionsSports participation, enjoyment of physical activityCC Penn State Worry Questionnaire (PSWQ) \[[@CR49]\]Parental worryM, FM, F Nijmeegse Ouderlijke Stress Index verkort (NOSIK) \[[@CR40]\]Parental stressM, FM, F Stress thermometer (DT-P) \[[@CR50]\]Parental stressM, FM, F Child Health Questionnaire (CHQ-PF50) \[[@CR51]\]Quality of life of child and siblingM, FM, F Short-form (36) Health Survey (SF-36) \[[@CR52]\]Quality of life of parentsM, FM, F Family Assessment Device, general functioning subscale (FAD) \[[@CR53]\]Family functioningM, FM, F Medical recordMedical consumptionRR Social validity questionnaireSatisfaction, attendance, and completion of CHIP-Family--M, FM, FPredictor variables Rotterdam Quality of Life interview \[[@CR30]\]Demographic variablesM, F-- Medical recordCardiac diagnosisRR Life event subscale of the Cognitive Emotion Regulation Questionnaire, child version (CERQ-k) \[[@CR44]\]Life eventsM, FM, F*M* Mother, *F* Father, *C* Child, *T* Teacher, *R* Medical recordsT1 = baseline, Direct follow-up = within 2 weeks after CHIP-Family intervention (only for participants in intervention group), T2 = follow-up, 6 months after T1

### Primary outcomes {#Sec12}

#### Child behavioral/emotional problems {#FPar1}

The problem section of the Child Behavior Checklist (CBCL) \[[@CR27]\] 1,½-5 (100 items; for 4- and 5-year-olds) and CBCL/6--18 (120 items; for 6- and 7-year-olds) will be used to obtain standardized parent reports of emotional and behavioral problems in their child. Response categories range from 0 to 2, with higher scores indicating more emotional and/or behavioral problems. Adequate reliability and validity have been reported \[[@CR28]\].

#### Parental mental health {#FPar2}

The Symptom Checklist-90-Revised (SCL-90-R) \[[@CR29]\] is a self-report scale (90 items; response categories: 1--5, higher score indicates more symptoms) which assesses 9 primary symptom dimensions: Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism. Adequate reliability and validity have been reported for the Dutch version \[[@CR29]\].

### Secondary outcomes {#Sec13}

#### School days sick/absent {#FPar3}

Through the Rotterdam Quality of Life interview \[[@CR30]\] parents and teachers will be asked how many days the child was absent from school and what the reasons for absence were.

#### Disease-specific knowledge and illness perception {#FPar4}

The Rotterdam Knowledge Questionnaire for Congenital Heart Disease \[[@CR31]\] is used to assess parents' knowledge about CHD and parents' illness perception.

#### School functioning {#FPar5}

The Dutch version of the Teacher's Report Form (C-TRF) 1½-5 (100 items) \[[@CR32]\] or the TRF/6--18 (120 items) \[[@CR33]\] will be completed by the teacher of the child. The TRF assesses problem behavior (at school). Response categories range from 0 to 2, with higher scores indicating more emotional and/or behavioral problems.

#### Executive functioning {#FPar6}

The Dutch Behavior Rating Inventory of Executive Functioning (BRIEF) \[[@CR34], [@CR35]\] (63 items; 2--5 years) and BRIEF-Preschool version (BRIEF-P) \[[@CR36]\] (86 items; 5--18 years) will be used to assess executive functioning skills in daily life. Response categories range from 0 to 2, with higher scores indicating more problems.

#### Enjoyment of leisure-time physical activity {#FPar7}

The Groningen Enjoyment Questionnaire (GEQ; 10 items; response categories 1--3, higher score indicates more enjoyment) \[[@CR37], [@CR38]\] is adjusted for parents and teachers and assesses enjoyment of physical activity. Children themselves answer two questions to assess how often they engage in physical activity and to assess enjoyment of physical activity.

#### Parental worry {#FPar8}

The Penn State Worry Questionnaire (PSWQ; 16 items; response categories 1--5, higher score indicates higher level of worry) \[[@CR39]\] assesses the excessiveness and uncontrollability of parental worry.

#### Parenting stress {#FPar9}

The Nijmeegse Ouderlijke Stress Index verkort (NOSIK) \[[@CR40], [@CR41]\] (25 items; response categories 1--6, higher score indicates higher level of stress) measures stress due to parenting. Parents will also complete the Distress Thermometer (DT-P) \[[@CR42]\] (40--42 items), which consists of a problem list and a thermometer on which parents are asked to rate their overall distress.

#### Quality of life of children and siblings {#FPar10}

The Child Health Questionnaire Parent Form-50 (CHQ-PF50; 50 items) \[[@CR43]\] is used to assess quality of life of the child with CHD and, if possible, of one sibling.

#### Parental quality of life {#FPar11}

The Short-form (36) Health Survey (SF-36) \[[@CR44]\] (36 items; score per domain 0--100, higher score indicates less disability) assesses eight health status domains: physical functioning, role limitations due to physical problems, bodily pain, general health, social functioning, role limitations due to emotional functioning, mental health, and vitality.

#### Family functioning {#FPar12}

The general functioning subscale of the Family Assessment Device (FAD) \[[@CR45]\] (12 items; response categories 1--4, higher total score indicates poorer functioning) assesses problem areas of family functioning.

#### Social validity {#FPar13}

Through a questionnaire, parents will be asked about their satisfaction regarding CHIP-Family. Furthermore, data on attendance and completion of CHIP-Family will be recorded.

### Predictors {#Sec14}

#### Demographic variables {#FPar14}

Demographic variables such as age, gender, and socio-economic status will be assessed through the Rotterdam Quality of Life interview \[[@CR30]\].

#### Medical variables {#FPar15}

Information about cardiac diagnosis, surgery, and intrusive procedures will be retrieved from medical records.

#### Life events {#FPar16}

The 'life events' subscale of the Cognitive Emotion Regulation Questionnaire child version (CERQ-k) \[[@CR44]\] is adjusted as such that parents can answer the questions about their child.

Sample size calculation {#Sec15}
-----------------------

To conduct a repeated measures ANOVA with two assessment moments, Cohen's d of 0.6, an alpha of .05 (two-tailed), and a power of .80, a sample size of 90 patients is needed, of which 45 patients in the intervention group.

Statistical analysis {#Sec16}
--------------------

To test the effectiveness of CHIP-Family on the primary outcome measures (for parents: mental health \[SCL-90-R\]; for children: behavioral/emotional problems \[CBCL\]) repeated measures ANOVAs will be conducted, for parental and child outcomes separately. Group (CHIP-Family versus CAU) will be the between-subjects variable and assessment (T1 versus T2) will be the within-subjects variable. Likewise, repeated measures ANOVAs will be conducted for the secondary outcome measures.

Additional regression analyses will be conducted to investigate in what way demographic factors, medical factors, and life events moderate the effect of CHIP-Family on the primary outcome measures.

Discussion {#Sec17}
==========

Several cohort and longitudinal studies have shown that there is a compelling need for a family-based psychosocial intervention for children with CHD and their families \[[@CR1]--[@CR3], [@CR18]--[@CR21]\]. Since key milestones such as starting kindergarten and primary school present more challenges for children with CHD and their parents than for families with healthy children \[[@CR20]\], an intervention tailored to their needs when starting school is needed. The previously examined CHIP-School intervention \[[@CR2]\], the only evidence-based psychosocial intervention for this population to date, significantly improved maternal mental health, diminished perceived strain on the family, and resulted in less school absence of the child. However, CHIP-School targeted parents only, aiming for an indirect effect on child psychosocial wellbeing. CHIP-School resulted in a non-significant, though positive, increase in child psychosocial wellbeing.

To improve these outcomes, we will modify and extend CHIP by adding a tailored child module for children with CHD and their siblings, thereby creating the CHIP-Family intervention. The child module consists of evidence-based cognitive behavioral and sports exercises. We will conduct an RCT to examine the effect of the innovated CHIP-Family intervention on parental mental health and psychosocial wellbeing of young children with CHD.

This study has several strengths. Firstly, if CHIP-Family proves to be effective, this would be the first evidence-based psychosocial intervention for young children with CHD and their families, thus meeting the previously described need for an intervention. Secondly, as recommended by the guidelines of the Association for European Pediatric Cardiology working group \[[@CR22]\], CHIP-Family provides early intervention. CHIP-Family aims to reduce and prevent psychosocial problems. As mental health problems in childhood may persist into adulthood \[[@CR22], [@CR46]\], the prevention of psychosocial problems is important. Thirdly, CHIP-Family is a family-centered intervention. It is widely acknowledged that family functioning and parental factors play an important role in children's development \[[@CR2], [@CR14], [@CR15]\]. As parents of children with CHD are at risk for psychosocial problems \[[@CR19]\], a family-centered intervention may reduce their problems \[[@CR47]\]. This, in turn, may enhance family functioning. Furthermore, siblings are involved in the workshop and receive attention from the hospital staff, which normalizes the position of the child with CHD.

In conclusion, this intervention aims to fulfill the need for an evidence-based family-centered psychosocial intervention for children with CHD and their families. If CHIP-Family proves to be effective in improving parental mental health and psychosocial wellbeing of children with CHD, it should be structurally implemented in standard care.

CAU

:   Care as usual

CHD

:   Congenital heart disease

CHIP

:   Congenital Heart disease Intervention Program

RCT

:   Randomized controlled trial
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